Snyder Alexandra

Snyder Alexandra

President at
Merck, Inc.
Finance
Consumer Services
Technology Services

Profile

Alexandra Snyder is a Principal at Two River.
Prior to joining Two River, Dr. Snyder was Associate Vice President of Global Clinical development at Merck, Inc, where she led Translational Oncology.
She was responsible for clinical trial execution, biomarkers, companion diagnostics, and quantitative pharmacology for Oncology.
Dr. Snyder featured frequently in FDA interactions about personalized medicine; her expertise in tumor genomics and neoantigens played a pivotal role in the approval of Keytruda (pembrolizumab) for tumor mutation burden-high tumors.
Before joining Merck, Dr. Snyder was Translational Medicine Lead at Adaptive Biotechnologies, a biotechnology company that develops T cell receptor-based diagnostics and therapeutics.
During her academic career, Dr. Snyder led clinical trials and a translational laboratory at Memorial Sloan Kettering Cancer Center (MSKCC).
Dr. Snyder received her B.A. from Princeton University, her M.D.
from Mount Sinai School of Medicine, Internal Medicine training at Mount Sinai Hospital and Fellowship at MSKCC.
Dr. Snyder is a board-certified medical oncologist and serves as voluntary faculty at Bellevue Hospital and NYU.

Snyder Alexandra active positions

CompaniesPositionStart
Private Equity Investor 01/08/2021
President -

Former positions of Snyder Alexandra

Training of Snyder Alexandra

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

91

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Finance

Consumer Services

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Snyder Alexandra